Guardant Health (GH) Co-CEO reports RSU vesting and tax share withholding
Rhea-AI Filing Summary
Guardant Health, Inc. Co-Chief Executive Officer AmirAli Talasaz reported routine equity compensation activity involving restricted stock units. On June 30 and July 1, 2026, a total of 36,529 restricted stock units converted into common stock through derivative exercises, reflecting scheduled vesting.
Across the same dates, 18,514 common shares were withheld and retained by the company at prices of $150.03 and $170.77 per share to cover tax liabilities associated with these vesting events. The transactions occurred through the Talasaz and Eskandari 2017 Family Trust and do not involve any open-market purchases or sales.
Positive
- None.
Negative
- None.
Insights
Form 4 shows RSU vesting with tax withholding, not open-market trading.
Co-CEO AmirAli Talasaz reported derivative exercises where restricted stock units converted into common stock. The filing aggregates 36,529 RSUs exercised into common shares and 18,514 shares withheld for taxes, based on the transaction summary.
The footnotes explain the company retained shares to satisfy tax withholding obligations upon vesting, with amounts not exceeding the tax liability. Because there are no open-market buys or sells, this is standard compensation-related activity and a weak informational signal about insider sentiment.
Insider Trade Summary
| Type | Security | Shares | Price | Value |
|---|---|---|---|---|
| Exercise | Restricted Stock Units | 23,997 | $0.00 | -- |
| Exercise | Restricted Stock Units | 9,715 | $0.00 | -- |
| Exercise | Common Stock | 23,997 | $0.00 | -- |
| Exercise | Common Stock | 9,715 | $0.00 | -- |
| Tax Withholding | Common Stock | 17,086 | $170.77 | $2.92M |
| Exercise | Restricted Stock Units | 2,817 | $0.00 | -- |
| Exercise | Common Stock | 2,817 | $0.00 | -- |
| Tax Withholding | Common Stock | 1,428 | $150.03 | $214K |
Footnotes (1)
- These shares were retained by the Company in order to meet the tax withholding obligations of the award-holder in connection with the vesting of an installment of the restricted stock units. The amount retained by the Company was not in excess of the amount of the tax liability. This represents a restricted stock unit award granted on March 17, 2026 that vests in four equal installments on the last day of each calendar quarter, March 31, 2026, June 30, 2026, September 30, 2026, and December 31, 2026. Not applicable for Restricted Stock Units. This represents a restricted stock unit award granted on March 18, 2024 that vests over a three-year period. 33% of the shares subject to such award vested on January 1, 2025 and the remaining 67% of the shares vests in equal quarterly installments over the remaining two-year period thereafter. This represents a restricted stock unit award granted on March 12, 2025 that vests over a three-year period. 33% of the shares subject to such award vested on January 1, 2026 and the remaining 67% of the shares vests in equal quarterly installments over the remaining two-year period thereafter.